↓ Skip to main content

Extracellular Vesicles and Chemotherapy Resistance in the AML Microenvironment

Overview of attention for article published in Frontiers in oncology, February 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
3 X users

Readers on

mendeley
81 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Extracellular Vesicles and Chemotherapy Resistance in the AML Microenvironment
Published in
Frontiers in oncology, February 2020
DOI 10.3389/fonc.2020.00090
Pubmed ID
Authors

Jill Nehrbas, John T. Butler, Ding-Wen Chen, Peter Kurre

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 81 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 18 22%
Student > Master 9 11%
Student > Bachelor 7 9%
Researcher 5 6%
Student > Postgraduate 4 5%
Other 10 12%
Unknown 28 35%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 26 32%
Medicine and Dentistry 11 14%
Immunology and Microbiology 5 6%
Unspecified 3 4%
Agricultural and Biological Sciences 2 2%
Other 4 5%
Unknown 30 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2022.
All research outputs
#16,588,485
of 26,163,973 outputs
Outputs from Frontiers in oncology
#5,841
of 22,911 outputs
Outputs of similar age
#277,160
of 486,808 outputs
Outputs of similar age from Frontiers in oncology
#137
of 459 outputs
Altmetric has tracked 26,163,973 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,911 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 486,808 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 459 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.